Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial

DOI Full Paper Access

103

Citations

36

References

2022

Year

Solange Peters, Rafał Dziadziuszko, Alessandro Morabito, Enriqueta Felip, Shirish M. Gadgeel, Parneet Cheema, Manuel Cobo, Zoran Andrić, Carlos H. Barrios, Masafumi Yamaguchi,

Nature Medicine

References

	Year	Citations

Page 1